Updated:
ESP Equity Partners
ESP Equity Partners LLC is a private investment company that invests in pharmaceutical and medical assets. It has made 3 investments, including a Series D...
ESP Equity Partners
ESP Equity Partners LLC is a private investment company that invests in pharmaceutical and medical assets. It has made 3 investments, including a Series D investment in EKR Therapeutics on March 17, 2008. The company has 1 portfolio exit, EKR Therapeutics, which occurred on May 16, 2012.
General information
Firm type
Private Equity
Year founded
2000
Location
Region
North America
Country
United States
City
Bedminster
Corporate office
Bedminster, NJ, United States
Frequently asked questions
Who founded ESP Equity Partners and who leads investment decisions today?
The firm's founders, leadership team, and key investment decision-makers are not disclosed in public records. ESP Equity Partners maintains a notably low public profile, and no named principals are available from its website or regulatory filings.
What is ESP Equity Partners' known track record or portfolio?
No specific portfolio companies, realized exits, or fund performance metrics are publicly available. ESP Equity Partners does not disclose its investment track record, portfolio composition, or fund-level returns through its website or standard industry data sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: